Health status in the TORCH study of COPD: treatment efficacy and other determinants of change. - Wikidata - awgldk - TriplyDB

Health status in the TORCH study of COPD: treatment efficacy and other determinants of change.

Health status in the TORCH study of COPD: treatment efficacy and other determinants of change.

http://www.wikidata.org/entity/Q35052737

about

Long-acting beta2-agonists for chronic obstructive pulmonary disease Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease Combined corticosteroid and long-acting beta 2 -agonist in one inhaler versus placebo for chronic obstructive pulmonary disease Does the duration of smoking cessation have an impact on hospital admission and health-related quality of life amongst COPD patients?Rescue medication use as a patient-reported outcome in COPD: a systematic review and regression analysis.Disability and recovery of independent function in obstructive lung disease: the cardiovascular health study.Validation of the new COPD assessment test translated into Thai in patients with chronic obstructive pulmonary disease.Differential changes in quality of life components over 5 years in chronic obstructive pulmonary disease patients.Efficacy and safety characteristics of mometasone furoate/formoterol fumarate fixed-dose combination in subjects with moderate to very severe COPD: findings from pooled analysis of two randomized, 52-week placebo-controlled trials.An Internet-Mediated Pedometer-Based Program Improves Health-Related Quality-of-Life Domains and Daily Step Counts in COPD: A Randomized Controlled Trial.Chronic Bronchitis Is Associated With Worse Symptoms and Quality of Life Than Chronic Airflow Obstruction.Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity.Dental health in smokers with and without COPD.Pharmacotherapies for COPD.SOSPES: SPIRIVA® observational study measuring SGRQ score in routine medical practice in Central and Eastern Europe Change in health status in COPD: a seven-year follow-up cohort study.Comparative efficacy of long-acting β2-agonists as monotherapy for chronic obstructive pulmonary disease: a network meta-analysis.Lower corticosteroid skin blanching response is associated with severe COPD.TIOtropium Safety and Performance In Respimat (TIOSPIR): Analysis of Asian cohort of COPD patients.Socioeconomic Status as a Determinant of Health Status Treatment Response in COPD Trials.Alteration of the irisin-brain-derived neurotrophic factor axis contributes to disturbance of mood in COPD patients.Validation of the chronic respiratory questionnaire in the Colombian population with chronic obstructive pulmonary disease.St George's Respiratory Questionnaire Score Predicts Outcomes in Patients with COPD: Analysis of Individual Patient Data in the COPD Biomarkers Qualification Consortium Database.Longitudinal changes in structural abnormalities using MDCT in COPD: do the CT measurements of airway wall thickness and small pulmonary vessels change in parallel with emphysematous progression?Determinants of 1-year changes in disease-specific health status in patients with advanced chronic obstructive pulmonary disease: A 1-year observational study.The effectiveness of a nurse-led illness perception intervention in COPD patients: a cluster randomised trial in primary care.Identifying prognostic factors in chronic obstructive pulmonary disease patients.Lung function and long-term safety of tiotropium/olodaterol in East Asian patients with chronic obstructive pulmonary disease.Post Hoc: Two (or More) for the Price of One.What have we learned from observational studies and clinical trials of mild to moderate COPD?Comparative efficacy of inhaled medications (ICS/LABA, LAMA, LAMA/LABA and SAMA) for COPD: a systematic review and network meta-analysis

P2860

Q24197467-09A763E7-E0D5-44CE-8F7A-88179B4600DB Q24197853-ACEAE524-E824-4E5A-9FCE-A04844B83A8D Q24197989-9420478B-24C0-4A53-AB96-EF4BBAA11CC6 Q24199130-A4FCF835-93A2-411B-A55E-29F4606C48FD Q24202510-1D2E8B1F-E736-46AF-AF69-011EABE543A5 Q33636975-92F044D3-B1D1-4A23-9579-F05C883FB0C5 Q33651564-D347E602-66D2-4AA1-AEC7-0D112B710C1E Q34342750-293CC666-1125-4ABB-8145-4852B978C873 Q34794305-D34607E4-2171-4969-B4A3-00C7967CE221 Q35460352-6CCF1ECD-E1C7-4510-A8CF-9AE12A7F9378 Q35747045-D4F1F03E-7F52-4F78-8D24-A197AC596E23 Q35825580-4B389FDB-9E41-464A-9962-8784F770CC74 Q35914605-5D8B0B13-75E3-4406-825E-C0A6A13B1AAC Q35915157-613AD2EC-0D67-45D3-8687-D9DBA908D2DE Q36721328-657B3590-2F92-48BB-A2CD-2B9FA2F48707 Q36843717-308BFCD7-ECB6-46A8-84D0-875E119DC8AE Q37249775-AFE60600-02BD-4E31-BAFE-ED3BF62A89C2 Q37353892-5CC89EF6-B40A-4A0E-A3DF-7D6DF7A957E2 Q37603579-2499213E-1849-4BAA-AA05-488227926507 Q37633157-7FA75B45-1948-4F86-893E-A80F9B8269D7 Q38411864-8BAC7A63-996E-4831-890F-E31D4A0424FF Q38604595-937B3186-7CFD-48C8-A34C-0E3906A2483A Q38651851-0A918042-4983-433F-9FF9-6B15486BCDF5 Q39040801-223AA1CA-B78A-4BA0-BD77-78FC6BC2BF3A Q40076551-C97C4DEB-3C8D-4657-954C-9584CF897B4B Q41991010-CC8DCA9F-FB7D-4848-AA17-33E9543D83DF Q44301197-9D1C500C-0FB1-4190-B7C8-620A1BC0ED95 Q47147311-63340330-ABF1-41B5-B0BA-981336728D49 Q47159343-1CC5598A-4BFC-4F65-8790-17B18FA78AE7 Q47375559-A42E962F-C233-4406-BCB7-3B6253E0C715 Q53930472-84B007E3-A338-45A7-8211-1CBFE20DDDCA Q57777296-29826177-FCBD-4BA1-9DBA-4AAFF95633B8 Q57817177-80EDD7BA-AB16-41F2-A24E-7C6822AB3EF0

P2860

Health status in the TORCH study of COPD: treatment efficacy and other determinants of change.

http://www.wikidata.org/entity/Q35052737

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Health status in the TORCH stu ...... other determinants of change.

@ast

Health status in the TORCH stu ...... other determinants of change.

@en

type

label

Health status in the TORCH stu ...... other determinants of change.

@ast

Health status in the TORCH stu ...... other determinants of change.

@en

prefLabel

Health status in the TORCH stu ...... other determinants of change.

@ast

Health status in the TORCH stu ...... other determinants of change.

@en

P1433

Q35052737-C42FB28C-EDBE-4F16-B9D1-82273A3E1C3A

P1476

Q35052737-B211C07A-1A4C-4676-B44C-32A9023D81B1

P2093

Q35052737-0882456E-F8B8-4FF6-9C7B-6C5110E01747

Q35052737-15467626-F92F-43F6-B3B8-C665AF6E511F

Q35052737-20D34374-047A-4A25-B4CE-99C73ED4FEE2

Q35052737-3EE5BAD7-7B00-4E80-8E23-EA3126A04327

Q35052737-88885EA2-B616-49FB-9D43-207B7C50F893

Q35052737-96C5DFAA-FB2C-4242-B5C4-85ED478B7471

Q35052737-9884853F-91FF-4DA1-9CDE-ECA82D81AAE9

Q35052737-D8FDF1E2-7584-462C-8A79-97A6CB7D3449

Q35052737-E004037C-80B6-421D-A414-ACF15CBF47D5

P2860

Q35052737-0ADAAF1C-895C-41D1-8357-29460D4EE91C

Q35052737-103AB9AE-8712-4049-99D2-24165ED6CDAE

Q35052737-1AEBF5C8-F7CA-4D2D-9979-C94E84D1933F

Q35052737-40392CD8-51B9-4F5B-98D4-E961BA979007

Q35052737-59C37B58-471E-4563-B55C-D58FAF1F8953

Q35052737-60104656-DA80-4AB4-B821-AF86B3B1C07F

Q35052737-741560D6-92D4-4715-8C07-CBC2BB583523

Q35052737-8FA9041D-F06B-4DAA-8993-7BEC6939F2E9

Q35052737-906747DF-C908-4805-9013-6225B731FE01

Q35052737-90F92C5D-FF55-43CB-8C77-208F8924D08B

P2888

Q35052737-953C13FD-2430-408F-84D9-321A8F693E43

P304

Q35052737-7D03EB7E-31AE-43E7-AF2C-8DF5A0B41309

P31

Q35052737-4255B09B-CA90-46D7-AD67-912E8B01AE77

P356

Q35052737-444236FA-91AF-4045-840B-EDC417D70061

P478

Q35052737-ECA6C7A4-F187-465F-9A49-A895863350AA

P50

Q35052737-1DBEE041-B7BF-494D-954E-4B01C77154CC

P577

Q35052737-D504E7BE-C1B9-4368-979E-FAD539422B4C

P5875

Q35052737-F02C7BF6-1BE0-40D6-B82F-53D21196C791

P6179

Q35052737-33336C48-9AD6-41EF-9270-35064D28D18D

P698

Q35052737-463E5ACF-8979-402F-87CC-83CF0662EEB9

P921

Q35052737-34FA9ACF-355D-4FC2-81F4-111E37EA86C0

P932

Q35052737-788A5DA4-72CA-49DE-994A-3A95D585C13C

P356

1465-9921-12-71

P1433

Respiratory Research

P1476

Health status in the TORCH stu ...... other determinants of change.

@en

P2093

Bartolome R Celli

http://www.w3.org/2001/XMLSchema#string

Christine Jenkins

http://www.w3.org/2001/XMLSchema#string

Gary T Ferguson

http://www.w3.org/2001/XMLSchema#string

Julie A Anderson

http://www.w3.org/2001/XMLSchema#string

Julie C Yates

http://www.w3.org/2001/XMLSchema#string

Michael D Spencer

http://www.w3.org/2001/XMLSchema#string

Paul W Jones

http://www.w3.org/2001/XMLSchema#string

Peter Ma Calverley

http://www.w3.org/2001/XMLSchema#string

TORCH investigators

http://www.w3.org/2001/XMLSchema#string

P2860

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

Health status measurement in chronic obstructive pulmonary disease.

Impact of preventing exacerbations on deterioration of health status in COPD.

Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial.

A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

The efficacy and safety of cilomilast in COPD.

Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease

Time course of recovery of health status following an infective exacerbation of chronic bronchitis.

Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study.

P2888

1465-9921-12-71

P304

71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1465-9921-12-71

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51179675

http://www.w3.org/2001/XMLSchema#string

P6179

1022696497

http://www.w3.org/2001/XMLSchema#string

P698

21627828

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

P932

3117702

http://www.w3.org/2001/XMLSchema#string